NEW YORK (GenomeWeb News) – Point-of-care diagnostic developer Micronics and Biosearch Technologies have struck a license agreement related to nucleic acid assay chemistries, Micronics said today.
Micronics has licensed the right to make, use, and sell products using Biosearch's fluorophores and quencher dyes.
The company is developing a line of point-of-care molecular diagnostic tests for infectious disease diagnosis and forensic testing. Based on Micronics' microfluidic tools that reduce the volume of a sample taken from a patient and the reagents required, the tests will target E. coli, malaria, and respiratory diseases.
Micronics will use Biosearch's Black Hole Quencher, CAL Fluor, and Quasar dye technologies, along with molecular beacons probe technology that Micronics licensed from PHRI Properties.